Ding, X. (2025) “Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study”, Acta Oncologica, 64, pp. 607–615. doi: 10.2340/1651-226X.2025.42652.